[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359789-105":59,"doc-detail-359789-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ube2m-promotes-malignant-phenotypes-of-prostate-cancer-through-mediating-naa10-neddylation","UBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation","","Prostate cancer is a common malignant tumor with high incidence and serious impact on men’s health. Neddylation is a key post-translational modification, and aberrant activity drives disease progression. UBE2M, the NEDD8-conjugating enzyme, is often overexpressed in cancers and links to tumor initiation, progression, metastasis, and therapy resistance, yet its prostate-cancer role is unclear. This study investigates UBE2M-mediated NAA10 neddylation and the downstream mechanisms affecting malignant behavior and prognosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ube2m-promotes-malignant-phenotypes-of-prostate-cancer-through-mediating-naa10-neddylation/359789/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ube2m-promotes-malignant-phenotypes-of-prostate-cancer-through-mediating-naa10-neddylation/359789.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn Holloway","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is UBE2M investigated in prostate cancer?","Question",{"text":112,"@type":113},"UBE2M is frequently overexpressed in multiple malignancies and is linked to tumor progression and therapy resistance, but its specific role and regulatory mechanisms in prostate cancer were not known.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study assess UBE2M expression and its effects?",{"text":117,"@type":113},"The researchers used bioinformatics and immunohistochemistry to validate elevated UBE2M in prostate cancer versus adjacent tissues, then used in vitro and in vivo functional assays (including CCK8, colony formation, and transwell assays with xenograft models) to test tumor behavior.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism connects UBE2M to prostate-cancer malignancy?",{"text":121,"@type":113},"NAA10 undergoes neddylation, mediated by the RBX1-CUL4A complex, with K148 identified as the key neddylation site; UBE2M enhances NAA10 protein stability and functional activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359789,1791176791,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Wang et al. Journal of Translational Medicine (2026) 24:599  \n[https://doi.org/10.1186/s12967-026-08001-8](https://doi.org/10.1186/s12967-026-08001-8)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nUBE2M promotes malignant phenotypes  of prostate cancer through mediating NAA10 neddylation  \nQixia Wang1,3†, Junyu Zhang2†, Xiang Lin1, Ruxue Shi3, Chenglong Pan3, Qingxia Hu3, Linlin Xu1, Qiaoyun Chen3, Dezhao Xue3, Junling Yin4*, Qiang Fu2* and Shuhong Huang1,3*  \nAbstract  \nBackground Prostate cancer (PCa) is a common malignant tumor in men, with a high incidence rate, posing a serious threat to human health and quality of life. Neddylation is a major post-translation modification, which is essential for multiple cellular behaviors. Aberrant neddylation has been implicated in the development and progression of various diseases. The NEDD8-conjugating enzyme UBE2M is frequently overexpressed in multiple types of malignancies and is closely associated with tumor initiation, progression, metastasis, and therapy resistance. However, the potential role of UBE2M in prostate cancer remains unknown.  \nMethods In our study, a bioinformatics analysis and Immunohistochemistry were employed to validate elevated UBE2M expression in prostate cancer compared to adjacent tissues. We assessed the impact of UBE2M on tumor progression using in vitro and in vivo functional experiments, including CCK8, colony formation, transwell assay and several animal models including PCa xenografts were employed to investigate the role of UBE2M in PCa progression. To elucidate the mechanism, we utilized Coimmunoprecipitation, Mass spectrometry analysis and Proximity ligationassay to elucidate the mechanisms by which UBE2M functions in prostate cancer cells.  \nResults We discovered that UBE2M expression is significantly elevated in prostate cancer tissues compared to adjacent paracancerous tissues, and this high UBE2M expression indicates a poorer prognosis for patients. Functional experiments demonstrated that overexpression of UBE2M promotes the proliferation and migration of prostate cancer cells, whereas knockdown of UBE2M inhibits these malignant phenotypes. Furthermore, we identified that NAA10 undergoes neddylation modification, and elucidated that the RBX1-CUL4A complex acts as the critical E3 ligase responsible for this modification, with the K148 site being the key neddylation site. We further confirmed that  \n†Qixia Wang and Junyu Zhang contributed equally to this work.  \n*Correspondence:  \nJunling Yin[chm_junlingyin@163.com](chm_junlingyin@163.com)[ ](chm_junlingyin@163.com)Qiang Fu  \n[qiangfu68@163.com](qiangfu68@163.com)[ ](qiangfu68@163.com)Shuhong Huang [shuhonghuang@sdfmu.edu.cn](shuhonghuang@sdfmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWang et al. Journal of Transla","cbCaieDRL2d09UCh","https://ap.wps.com/l/cbCaieDRL2d09UCh","pdf",4542382,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Neddylation and androgen receptor therapy context\n## UBE2M as a central node in neddylation","[{\"question\":\"Why is UBE2M investigated in prostate cancer?\",\"answer\":\"UBE2M is frequently overexpressed in multiple malignancies and is linked to tumor progression and therapy resistance, but its specific role and regulatory mechanisms in prostate cancer were not known.\"},{\"question\":\"How did the study assess UBE2M expression and its effects?\",\"answer\":\"The researchers used bioinformatics and immunohistochemistry to validate elevated UBE2M in prostate cancer versus adjacent tissues, then used in vitro and in vivo functional assays (including CCK8, colony formation, and transwell assays with xenograft models) to test tumor behavior.\"},{\"question\":\"What mechanism connects UBE2M to prostate-cancer malignancy?\",\"answer\":\"NAA10 undergoes neddylation, mediated by the RBX1-CUL4A complex, with K148 identified as the key neddylation site; UBE2M enhances NAA10 protein stability and functional activity.\"}]","UBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation | PDF",1790137828,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/040ed357096472ffe8b001335f0013e3.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/817866822cca769292112964638fc3d0.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50375294406022a1b3b72acf4752c536.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/074e807d499619ad6d182c8813f5fa6a.webp",980,1306]